Search for content and authors
dr Monika Lamparska-Przybysz
e-mail:
Sorry, you need javascript to view this email address
phone:
fax:
web:
interest(s):
Affiliation:
Celon Pharma Ltd.
address:
, Kiełpin, 05-092,
Poland
phone:
fax:
web:
Participant:
VII Multidyscyplinarna Konferencja Nauki o Leku
began:
2010-05-09
ended:
2010-05-13
Presented:
VII Multidyscyplinarna Konferencja Nauki o Leku
Novel small molecule STAT3 inhibitors in cancer therapy.
Participant:
VIII Multidyscyplinarna Konferencja Nauki o Leku
began:
2012-05-29
ended:
2012-06-02
Presented:
VIII Multidyscyplinarna Konferencja Nauki o Leku
CPL-200-075, a novel potent renal sodium-glucose cotransporter 2 (SGLT2) inhibitor
Publications:
CPL-200-075, a novel potent renal sodium-glucose cotransporter 2 (SGLT2) inhibitor
Design and development of CPL-407-22 – novel, potent and selective JAK2 protein kinase inhibitor.
Novel small molecule STAT3 inhibitors in cancer therapy.
RNAi - breakthrough technology gives hope for breakthrough therapeutics
Web
science24.com
© 1998-2024
pielaszek research
, all rights reserved
Powered by
the Conference Engine
